Mustang Bio, INC. (MBIO) SEC Filings — 2025

Filings

• Mustang Bio Files 8-K for Shareholder Vote & Other Events — 8-K · Dec 23, 2025
• Mustang Bio Seeks Shareholder Approval for Equity Plan Boosts, Director Slate — DEF 14A · Dec 3, 2025
• Mustang Bio Narrows Losses, Boosts Cash Amid Going Concern Doubts — 10-Q · Nov 7, 2025
• Mustang Bio Navigates Cash Burn, Leans on Equity for Survival — 10-Q · Aug 8, 2025
• Mustang Bio Files 8-K: Corporate Updates — 8-K · Jul 9, 2025
• Mustang Bio Files Q1 2025 10-Q — 10-Q · May 14, 2025
• Mustang Bio Files 2024 Annual Report — 10-K · Mar 28, 2025
• Mustang Bio Files 8-K: Corporate Updates — 8-K · Mar 5, 2025
• Mustang Bio Completes Asset Acquisition/Disposition — 8-K · Feb 27, 2025
• Mustang Bio Files 8-K on Security Holder Vote Matters — 8-K · Feb 21, 2025
• Mustang Bio Terminates Material Definitive Agreement — 8-K · Feb 13, 2025
• Mustang Bio Enters Material Definitive Agreement — 8-K · Feb 11, 2025
• Mustang Bio Files S-1/A Amendment — S-1/A · Feb 5, 2025
• Mustang Bio Sells Subsidiary, Focuses on Gene Therapy — 8-K · Jan 17, 2025
• Mustang Bio Files S-1 with SEC — S-1 · Jan 15, 2025
• Mustang Bio Files 8-K on Shareholder Vote Matters — 8-K · Jan 10, 2025
• Mustang Bio Files 8-K on Shareholder Vote Matters — 8-K · Jan 2, 2025